SHI Group is a consortium of sister companies that work within the international healthcare and life sciences space. We deliver innovative strategies and implementation-oriented solutions to industry, government, academia, not-for-profit organizations and care providers throughout the world.
SHI Capital is a boutique investment bank that provides financial and strategic advisory services related to mergers and acquisitions, divestitures, equity capital and debt financing, and actively manages technology commercialization.
SHI Capital facilitates transactions across many sectors with a clear and distinct focus on the healthcare and life sciences industries. Our unique methodology is founded on a deep technical understanding and on broad experience in mediating financial transactions.
SHI Ventures is an angel investment vehicle that focuses on undervalued assets or transitional companies with superior management teams capable of quick market advancements (both public and private). Within the life sciences industry, we focus on therapeutics, diagnostics, medical foods and nutraceuticals, health information technology and medical devices.
SHI Ventures takes both a passive and active role in the investment process including due diligence, valuation, leading or following an investment round, board representation and follow-on strategic advice.
In order to download the PDF, please fill out the following form: